Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5025,299.351.02%H 25,384.8 · L 25,142.95as of 12 Nov, 3:31 PM IST|Sensex81,911.010.99%H 82,325.61 · L 81,576.15as of 12 Nov, 3:32 PM IST|Bank Nifty61,518.52.97%H 61,545.85 · L 60,723.1as of 12 Nov, 3:31 PM IST|USD / INR₹94.040.38%H ₹94.05 · L ₹93.6as of 3:34 AM IST|Gold Intl (10g)₹1,17,421.880.04%H ₹1,17,458.16 · L ₹1,17,334.2upd. 4:34 AM IST|Silver Intl (1kg)₹1,51,187.810.12%H ₹1,51,202.93 · L ₹1,51,021.52upd. 4:34 AM IST|Crude WTI₹8,352.630.09%H ₹8,359.22 · L ₹8,341.35upd. 4:34 AM IST|Bitcoin₹67,16,7802.39%H ₹67,97,056.09 · L ₹66,36,503.91upd. 4:44 AM IST|Ethereum₹1,89,5500.64%H ₹1,90,154.97 · L ₹1,88,945.03upd. 4:44 AM IST|Nifty 5025,299.351.02%H 25,384.8 · L 25,142.95as of 12 Nov, 3:31 PM IST|Sensex81,911.010.99%H 82,325.61 · L 81,576.15as of 12 Nov, 3:32 PM IST|Bank Nifty61,518.52.97%H 61,545.85 · L 60,723.1as of 12 Nov, 3:31 PM IST|USD / INR₹94.040.38%H ₹94.05 · L ₹93.6as of 3:34 AM IST|Gold Intl (10g)₹1,17,421.880.04%H ₹1,17,458.16 · L ₹1,17,334.2upd. 4:34 AM IST|Silver Intl (1kg)₹1,51,187.810.12%H ₹1,51,202.93 · L ₹1,51,021.52upd. 4:34 AM IST|Crude WTI₹8,352.630.09%H ₹8,359.22 · L ₹8,341.35upd. 4:34 AM IST|Bitcoin₹67,16,7802.39%H ₹67,97,056.09 · L ₹66,36,503.91upd. 4:44 AM IST|Ethereum₹1,89,5500.64%H ₹1,90,154.97 · L ₹1,88,945.03upd. 4:44 AM IST|
0%
Investment Ideas

Sakar Healthcare Stock Surges 350% in 5 Years on Strong Profit Growth

Arth Vani DeskPublished: 1 min read
Sakar Healthcare Stock Surges 350% in 5 Years on Strong Profit Growth

Source: Mint Markets

Arth Insight · What this means for your wallet

Immediate action
Check your portfolio's sector allocation to ensure you aren't over-exposed to high-valuation pharma stocks.
  • A 350% return turns a ₹1 lakh investment into ₹4.5 lakh, highlighting the wealth-building power of long-term equity holding.
  • The 120% profit jump suggests strong business health, which often leads to higher dividends or further stock price appreciation.
  • Rapid surges can lead to high 'Price-to-Earnings' ratios, meaning new investors might pay a premium price for future growth.
Recommended for you
Discover financial products for you
Explore
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

Sakar Healthcare's share price saw a significant jump, trading at ₹817.45 today, following a 120% year-on-year rise in net profit for Q1 FY27. The stock has delivered a remarkable 350% return over the past five years.

Key Highlights
  • ▸Sakar Healthcare stock is trading higher after reporting a 120% profit jump in Q1 FY27.
  • ▸The stock has delivered a 350% return over the last five years.
  • ▸The company's strong financial performance has led to significant shareholder value creation.
Key Takeaways
  • ✓Sakar Healthcare stock is trading higher after reporting a 120% profit jump in Q1 FY27.
  • ✓The stock has delivered a 350% return over the last five years.
  • ✓The company's strong financial performance has led to significant shareholder value creation.

Sakar Healthcare's stock opened at ₹817.45 today, up from its previous close of ₹802.20, reaching an intraday high of ₹833.90 on July 27. This surge follows the company's impressive financial results, which reported a 120% year-on-year increase in net profit for the first quarter of the fiscal year 2027 (Q1 FY27).

Over the last five years, Sakar Healthcare has demonstrated exceptional growth, with its share price rallying by approximately 350%. This sustained performance indicates strong investor confidence and robust operational execution by the company.

The company's financial performance in Q1 FY27 highlights its ability to significantly boost profitability. While specific figures for the net profit amount were not provided in the source material, the percentage increase suggests a substantial improvement in earnings.

Investors in Sakar Healthcare have benefited from this upward trend. The stock's consistent rally over half a decade points to its status as a multibagger, rewarding early investors with substantial returns. The recent profit jump is likely to further fuel interest in the stock.

This article is for informational purposes only and does not constitute investment advice.

Recommended for you
Products related to this story — compare & act
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
13.9%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
13.9%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
13.5%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
12.7%
3Y CAGR

Mutual fund data is sourced from AMFI and shown for information only — funds are subject to market risks. Read all scheme-related documents carefully. Some listings may be sponsored. Not investment advice.

Frequently Asked Questions

What is Sakar Healthcare's recent stock performance?

Sakar Healthcare's stock opened at ₹817.45 today, up from ₹802.20, and reached an intraday high of ₹833.90 on July 27. It has rallied 350% in five years.

Why has Sakar Healthcare's stock seen a surge?

The stock surge is attributed to the company reporting a 120% year-on-year rise in net profit for Q1 FY27.

What does a 'multibagger' stock mean?

A multibagger stock is one that provides returns of more than 100%, significantly multiplying the initial investment.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.

Related Stories

PepsiCo Stock Analysis: Is the Global Beverage Giant Trading Below Its Fair Value?
Investment Ideas

PepsiCo Stock Analysis: Is the Global Beverage Giant Trading Below Its Fair Value?

Financial analysis suggests that PepsiCo (PEP) may be undervalued based on its future cash flow projections. For Indian investors trading in US stocks, this presents a potential opportunity to evaluate a defensive consumer staple at a discount.

16h ago·1 min readListen
Coinbase Stock Faces Uncertainty After Prediction Market Ruling
Investment Ideas

Coinbase Stock Faces Uncertainty After Prediction Market Ruling

A recent ruling impacting prediction markets could significantly alter the investment case for Coinbase stock (COIN). This development raises questions about the future regulatory landscape for crypto-related assets and platforms.

3d ago·1 min readListen
Tenneco Clean Air India Slips Below IPO Price: Value Buy or Cautionary Tale?
IPOBreaking
Investment Ideas

Tenneco Clean Air India Slips Below IPO Price: Value Buy or Cautionary Tale?

Shares of Tenneco Clean Air India are currently trading below their initial public offering price, sparking debate among retail investors. While the dip presents a potential entry point for long-term value seekers, market experts urge a close look at the company's fundamentals and the broader automotive sector's performance.

3d ago·1 min readListen
GlobalFoundries Stock May Be Nearing Fair Value After 35% Decline
Investment Ideas

GlobalFoundries Stock May Be Nearing Fair Value After 35% Decline

According to Simply Wall St, semiconductor manufacturer GlobalFoundries (GFS) stock may be approaching its fair value following a significant 35% drop. This analysis suggests the stock could offer better value to investors after its recent correction.

5d ago·1 min readListen